Zeke Capital Advisors’s BioMarin Pharmaceuticals BMRN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2014
Q4
Sell
-40,300
Closed -$2.91M 75
2014
Q3
$2.91M Hold
40,300
2.64% 8
2014
Q2
$2.51M Hold
40,300
2.02% 11
2014
Q1
$2.75M Hold
40,300
2.38% 8
2013
Q4
$2.84M Hold
40,300
2.6% 10
2013
Q3
$2.91M Hold
40,300
2.74% 9
2013
Q2
$2.25M Buy
+40,300
New +$2.25M 1.84% 9